Alessandro A.
- Country
- Italy
- Department
- UOC Gastroenterologia
Research Overview
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
- Phase II Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Patients with Moderate to Severe Ulcerative Colitis
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
Data & Insights
Has run more than one trial at 299 of 512 partner sites.
Specializations
Inflammatory Bowel Disease
The investigator specializes in treating ulcerative colitis and Crohn's disease, with particular focus on moderate to severe manifestations. Their work encompasses innovative therapeutic approaches for patients with various presentations, including those with ileostomy.
- Advanced Ulcerative Colitis Management
- Crohn's Disease Treatment Strategies
- Post-surgical Care in IBD
Eosinophilic Disorders
Expertise in treating various eosinophilic gastrointestinal conditions, including eosinophilic esophagitis (EoE), eosinophilic gastritis, and eosinophilic duodenitis. Their work addresses both adult and adolescent patient populations.
- Esophageal Inflammation Management
- Gastric Eosinophilic Conditions
- Combined Eosinophilic Disorders
Specialized Gastrointestinal Conditions
The investigator addresses complex gastrointestinal disorders including Short Bowel Syndrome, Intestinal Failure, and gastroparesis. Their expertise extends to both idiopathic and diabetic manifestations of these conditions.
- Intestinal Failure Management
- Gastroparesis Treatment
- Functional Bowel Disorders
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.